APP and Alzheimer disease: Acitretin was reported to increase the levels of the α-secretase (ADAM10) of amyloid-β protein precursor (AβPP), driving the non-amyloidogenic pathway in neuroblastoma cells with reduction in Aβ levels in APP/PS-1 AD model mice [27].